GSK Scrambles For N11.16bn To Payoff Stanbic Nominee, Other Shareholder Ahead Of Wind Down

Glaxo Smithkline Consumer Nigeria Plc which is finalising its exit from Nigerian is planning about N11.16bn settlement package for its shareholders.

The group said in the unaudited financial statement for 2023 seen by THE WHISTLER that it is only engaging in activities necessary to wind down the business and affairs of GSK Nigeria.

THEWHISTLER : Read More